ベータブロッカーのがん神経免疫学への影響:生存結果と免疫調節の体系的レビューとメタ解析
Fangyuan Zhang1,2, Yu Wang3, Feng Liu3
1Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Frontiers in immunology
|August 22, 2025
まとめ
ベータブロッカーは全生存効果を示さないが,免疫療法と併用すると,特に乳がんとメラノーマでは改善する. しかし,BBは臓がんや頭頸部がんに害を及ぼし,個別化された治療戦略を必要とします.
科学分野:
- 腫瘍学
- 薬理学について
- 免疫学
背景:
- ベータブロッカーは,神経免疫軸経由でがんの進行に影響を与える可能性があります.
- ガン生存と免疫調節に対するBBの影響に関する臨床データは矛盾しています.
- 様々な悪性腫瘍における BBsの役割を明確にするために,包括的な評価が必要である.
研究 の 目的:
- ベータブロッカーのがん生存結果への影響を体系的に検討し,メタ分析する.
- 異なる癌の免疫調節に対するBBの影響を評価する.
- BBクラスと併用免疫療法による差異的効果を調査する.
主な方法:
- 主要なデータベース (PubMed,Embase,Web of Science) の79件の研究を体系的にレビューし,メタ分析した.
- 総合生存率 (OS) と癌特異生存率 (CSS) の総合リスク比 (HRs) を計算した.
- サブグループ分析では,がんのタイプ,BBクラス,および免疫療法による効果が検討され,免疫バイオマーカーが合成されました.
主要な成果:
- CSSに対するBBの全体的な有意な効果は認められず (HR=0. 97),かなりの異質性が見られた.
- 乳がんとメラノーマの予防効果; 臓がんと頭頸部がんの有害効果
- 免疫チェックポイント阻害剤 (ICI) の併用療法により,特にPD- L1+腫瘍の生存率 (HR=0. 91) が改善されました. 非選択的BBはより強い免疫調節を示した.
結論:
- ベータブロッカーは,免疫療法と併用すると,特にメラノーマや乳がんなどの特定の癌の治療に有益です.
- 臓がんや頭頸部がんでは,BBが有害である可能性があり,慎重に患者を選択する必要があることを示唆しています.
- 免疫療法で治療されたメラノーマではプロプラノロールが潜在的な選択肢として,腫瘍のタイプとアドレナージクプロファイリングを考慮して個別化されたBBの使用が推奨されます.
関連する概念動画
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
972
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
972
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Heart Failure Drugs: β-Blockers
434
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
434
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453
Antihypertensive Drugs: Types of β-Blockers
867
β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...
867
Psychoneuroimmunology: Diabetes and Cancer
62
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
62


